SCIER Author Services

今天，我们来看看这本SCI期刊：JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS。从现有的记录来看，JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS 的2021年影响因子(JCR2020)是3.935，自引率6.45%。

关于此刊的具体情况，大家可以看看：

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS 的收稿范围，期刊是如此介绍的(截取部分内容)，详情请阅读：

https://www.sciencedirect.com/journal/journal-of-pharmaceutical-and-biomedical-analysis/about/aims-and-scope

This journal is an international medium directed towards the needs of academic, clinical, government and industrial analysis by publishing original research reports and critical reviews onpharmaceuticalandbiomedical analysis. It covers the interdisciplinary aspects of analysis in the pharmaceutical, biomedical andclinical sciences, including developments in analytical methodology, instrumentation, computation and interpretation. Submissions on novel applications focusing on drug purity and stability studies, pharmacokinetics, therapeutic monitoring, metabolic profiling; drug-related aspects of analytical biochemistry and forensic toxicology; quality assurance in the pharmaceutical industry are also welcome.

期刊接受时间

• Received 8 November 2021; Accepted 6 March 2022

• Received 26 December 2021; Accepted 28 January 2022

• Received 23 November 2021; Accepted 25 February 2022

期刊年发文量

对于 JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS 的发文量，2018年发文720多篇，2019年发文610多篇，2020年发文680多篇，2021年发文740多篇，截止2022年5月4日已发文110多篇。

影响因子

即时影响因子计算发现，2022年5月4日，3.522分。按照常规期刊计算方法，以及往年经验，在2022年6月份公布的IF中，它或许在3.5分左右！期待6月份新IF的公布！

如果还没有注册过账户，只需点击“Register Now”注册账户即可！

版权声明：本文转自“51选刊”，文章转载只为学术传播，不代表本号观点，无商业用途，版权归原作者所有，如涉及侵权问题，请联系我们，我们将及时修改或删除。